Skip to Main Content
Try STAT+ TODAY
Trending:
The Obesity Revolution
Biotech
Health
STAT+
Subscribe Now To access exclusive content, subscribe to STAT+
View Latest View the latest STAT+ stories
Biotech
STAT+

The STAT Plus spreadsheet: Salaries and stock prices at 162 biotechs

  • Damian Garde

By Damian Garde May 5, 2017

Reprints

We’ve combed through the filings of all 162 companies on the Nasdaq Biotech Index to look at how CEO compensation fared last year — and to match that up against stock performance.

We put together an exclusive spreadsheet for Plus subscribers with all that info. Have thoughts about the data? Email me at [email protected]

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

About the Author Reprints

Damian Garde

Damian Garde

National Biotech Reporter

Damian Garde covers biotech, is a co-writer of The Readout newsletter, and a co-host of "The Readout LOUD" podcast.

Tags

Cases of Marburg going unreported in Equatorial Guinea, WHO…
Cases of Marburg going unreported in Equatorial Guinea, WHO says
A half century after Prozac, a new generation of…
A half century after Prozac, a new generation of depression drugs is bringing hope to a…
Why drug prescriptions should include diagnoses
Why drug prescriptions should include diagnoses
Is there $21 billion left for Covid response, or…
Is there $21 billion left for Covid response, or $5 billion? The White House is using…
Dutch health minister won’t cover a Gilead cancer drug…
Dutch health minister won’t cover a Gilead cancer drug due to the cost
NIH releases data showing more clinical trial sponsors are…
NIH releases data showing more clinical trial sponsors are reporting results, but most miss deadlines

Recommended Stories